Louise joined HGF in September 2018 and qualified as a European Patent Attorney in July 2022.
Louise's background and qualifications are in chemistry. She graduated in 2013 with a First Class MSci honours degree in Chemistry and obtained her PhD in 2018, both from the University of Birmingham. Louise's PhD research involved the de novo design of peptide architectures for use as imaging agents.
Alongside her undergraduate studies, Louise also worked in industry, undertaking two summer placements in the Research and Development team at Scott Bader.
During her PhD she spent two months working with collaborators in San Sebastian. This work was presented at several international conferences and resulted in a number of publications.
Following the completion of her PhD, Louise completed two research fellow posts at the University of Birmingham, the first in the School of Chemistry and the second in the Institute of Microbiology and Infection. Here she explored topical treatments for age-related macular degeneration, presenting her work at the ARVO Annual Meeting in Hawaii. Alongside this project, she assisted in researching the development of smart coatings for implant materials.
MSci, Chemistry, 2013
PhD, Chemistry, 2017
PG Cert, Intellectual Property Law, 2019
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …Event details
Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …Event details
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.